Researchers created three different types of chimeric MrNV VLPs that had specificity toward the epidermal growth factor receptor (EGFR), a cancer cell biomarker, by incorporating the EGFR-specific GE11 peptide at three different locations within the host cell recognition site of the capsid.
[Scientific Reports]